Literature DB >> 20628338

Complications and concerns with osteobiologics for spine fusion in clinical practice.

Steven D Glassman1, Jennifer M Howard, Alexander Sweet, Leah Y Carreon.   

Abstract

STUDY
DESIGN: Literature-based topic review.
OBJECTIVE: To review the complications and the concerns that may be associated with all of the commonly used osteobiologic options for spine fusion. SUMMARY OF BACKGROUND DATA: Obtaining a solid arthrodesis is an important objective in many lumbar surgical procedures, and a wide array of bone graft materials may be used in an attempt to achieve this goal. Iliac crest bone graft, as well as all of the available osteobiologic alternatives, carries potential risks and concerns for both patient and surgeon.
METHODS: Review of literature and expert opinion.
CONCLUSION: Some of the potential complications associated with osteobiologic materials used in spinal fusion are well understood and clearly documented whereas others require further study and clarification. In any given clinical situation, the patient and surgeon need to balance the benefits and performance characteristics of the graft material with the risk profile to optimize clinical management.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20628338     DOI: 10.1097/BRS.0b013e3181ce11cc

Source DB:  PubMed          Journal:  Spine (Phila Pa 1976)        ISSN: 0362-2436            Impact factor:   3.468


  10 in total

1.  Effects of a perfusion bioreactor activated novel bone substitute in spine fusion in sheep.

Authors:  Jesper Roed Sørensen; Kariatta Ester Koroma; Ming Ding; David Wendt; Stig Jespersen; Maria Vinther Juhl; Naseem Theilgaard; Ivan Martin; Søren Overgaard
Journal:  Eur Spine J       Date:  2012-07-10       Impact factor: 3.134

Review 2.  A systematic review of comparative studies on bone graft alternatives for common spine fusion procedures.

Authors:  Charla R Fischer; Ryan Cassilly; Winifred Cantor; Emmanuel Edusei; Qusai Hammouri; Thomas Errico
Journal:  Eur Spine J       Date:  2013-02-26       Impact factor: 3.134

3.  Prospective analysis of a new bone graft in lumbar interbody fusion: results of a 2- year prospective clinical and radiological study.

Authors:  Philippe Lauweryns; Yannic Raskin
Journal:  Int J Spine Surg       Date:  2015-02-03

4.  Transforaminal lumbar interbody fusion rates in patients using a novel titanium implant and demineralized cancellous allograft bone sponge.

Authors:  Gerard Girasole; Gerard Muro; Abraham Mintz; Jason Chertoff
Journal:  Int J Spine Surg       Date:  2013-12

Review 5.  Allograft Versus Demineralized Bone Matrix in Instrumented and Noninstrumented Lumbar Fusion: A Systematic Review.

Authors:  Zorica Buser; Darrel S Brodke; Jim A Youssef; Elke Rometsch; Jong-Beom Park; S Tim Yoon; Jeffrey C Wang; Hans-Joerg Meisel
Journal:  Global Spine J       Date:  2017-10-25

6.  Fusion Rates of Lateral Lumbar Interbody Fusion Using Recombinant Human Bone Morphogenetic Protein-2.

Authors:  Ardalan A Nourian; Justin Harrington; Pamela A Pulido; Julie C McCauley; James D Bruffey; Robert K Eastlack
Journal:  Global Spine J       Date:  2018-09-25

7.  Use of Autologous Stem Cells in Lumbar Spinal Fusion: A Systematic Review of Current Clinical Evidence.

Authors:  Zorica Buser; Patrick Hsieh; Hans-Joerg Meisel; Andrea C Skelly; Erika D Brodt; Darrel S Brodke; Jong-Beom Park; S Tim Yoon; Jeffrey Wang
Journal:  Global Spine J       Date:  2020-11-18

8.  Rare complications of osteolysis and periprosthetic tissue reactions after hybrid and non-hybrid total disc replacement.

Authors:  Sai Y Veruva; Todd H Lanman; Josa A Hanzlik; Steven M Kurtz; Marla J Steinbeck
Journal:  Eur Spine J       Date:  2014-08-28       Impact factor: 3.134

9.  Recombinant human Bone Morphogenetic Protein-2 (rhBMP-2) in posterolateral lumbar spine fusion: complications in the elderly.

Authors:  Martin F Hoffmann; Clifford B Jones; Debra L Sietsema
Journal:  J Orthop Surg Res       Date:  2013-01-14       Impact factor: 2.359

10.  Recombinant Human Bone Morphogenetic Protein-2 in Posterolateral Spinal Fusion: What's the Right Dose?

Authors:  Martin Franz Hoffmann; Clifford Barry Jones; Debra Lynn Sietsema
Journal:  Asian Spine J       Date:  2016-06-16
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.